表紙
市場調查報告書

流感疫苗的全球市場

Global Market Study on Flu Vaccines: Preventive over Reactive

出版商 Persistence Market Research 商品編碼 905985
出版日期 內容資訊 英文 195 Pages
商品交期: 2-3個工作天內
價格
Back to Top
流感疫苗的全球市場 Global Market Study on Flu Vaccines: Preventive over Reactive
出版日期: 2019年07月22日內容資訊: 英文 195 Pages
簡介

本報告提供全球流感疫苗市場的相關調查,提供市場機會,需求及預測,成長及阻礙因素,產品類型·投藥形態·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場覆蓋率/分類
  • 市場定義/範圍/限制

第3章 主要市場趨勢

  • 影響市場的主要趨勢

第4章 全球流感的疫苗的市場需求(銷售額或規模:100萬美元)分析及預測

  • 過去的市場分析
  • 現在/未來市場預測
    • 與前一年同期比較成長趨勢分析

第5章 市場背景

  • 宏觀經濟要素
    • 全球醫療保健支出預測
  • 預測要素-相關性及影響
    • 疫苗接種率
    • 流感及流感疫苗接種相關的認識
    • 流感疫苗的可得性
    • 全球國家的流感疫苗的需求
    • 廠商間的聯盟
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會分析

第6章 全球流感疫苗的市場分析及預測:各產品類型

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在/未來市場分析及預測
    • 三價流感疫苗
    • 四價流感疫苗
  • 市場魅力分析

第7章 全球流感疫苗的市場分析及預測:不同投藥形態

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在/未來市場分析及預測
    • 肌肉內注射
    • 鼻子噴霧
    • 皮內注射
  • 市場魅力分析

第8章 全球流感疫苗的市場分析及預測:各流通管道

  • 簡介/主要調查結果
  • 過去的市場分析
  • 現在/未來市場分析及預測
    • 機關
    • 零售
  • 市場魅力分析

第9章 全球流感疫苗的市場分析及預測:各地區

  • 簡介
  • 過去的市場及交易數量分析
  • 目前市場,交易數量分析及預測
    • 北美
    • 南美
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東及非洲地區(MEA)
  • 市場魅力分析

第10章 北美的流感疫苗市場分析及預測

  • 簡介
  • 過去的市場及交易數量趨勢分析:市場分類法
  • 市場及交易數量的預測:市場分類法
    • 各國
    • 各產品類型
    • 不同投藥形態
    • 各流通管道
  • 市場魅力分析
  • 成長要素及規定:影響分析

第11章 南美的流感疫苗市場分析及預測

第12章 歐洲的流感疫苗市場分析及預測

第13章 南亞的流感疫苗市場分析及預測

第14章 東亞的流感疫苗市場分析及預測

第15章 大洋洲的流感疫苗市場分析及預測

第16章 中東及非洲的流感疫苗市場分析及預測

第17章 市場結構分析

  • 市場分析:企業的各層級(流感疫苗)
  • 主要企業的市場佔有率分析
  • 市場影響分析
    • 各地區:企業的足跡
    • 各企業:產品足跡
    • 各企業:流通管道的足跡

第18章 競爭分析

  • 競爭儀表板
  • 競爭的基準
  • 企業簡介
    • Sanofi Pasteur Inc. (Sanofi S/A)
    • AstraZeneca
    • CSL Ltd. (Seqirus)
    • Abbott
    • GlaxoSmithKline Plc.
    • Serum Institute of India Pvt. Ltd.

第19章 調查方法

目錄

Analysis and Opportunity Assessment:

Persistence Market Insights (PMR), in its new publication, outlines the growth trails of 'Flu Vaccine Market' for the period between 2019 and 2029. The study includes a thorough analysis of historical and current trends that can impact the future development of flu vaccine market. It offers various drivers, restrains, challenges, and opportunities in the flu vaccine market. The report brings to fore actionable insights on nodes and internodes of the flu vaccine market that can arm the vendors with necessary information to take critical decision with confidence.

PMR's study covers a key indicator assessment to estimate the growth prospects of the flu vaccine market during the predefined period, along with forecast statistics in terms of value (US$ million). In addition, the report consists of multiple sections explaining the global healthcare spending outlook and awareness about flu and flu vaccination.

Readers can find a detailed taxonomy in the report, along with an incisive outlook on the competitive landscape in flu vaccine market. The study profiles a number of incumbent companies and new entrants in the flu market, wherein, product portfolio, new launches, technological innovations, and dynamic growth strategies of these players have been detailed.

Segmentation:

Key information featured in the flu vaccine market report has been segmented into four broader categories - type, dosage form, distribution channel, and region. The report includes different dynamics and trends related to individual segments, and assesses their impact on the overall growth of the flu vaccine market. Market value share analysis and market attractiveness assessment of the segments have also been provided in this section of the report.

What are the Key Questions Answered in the Flu Vaccine Market Report?

PMR's study assesses the flu vaccine market at both macroscopic and microscopic levels to offer detailed insights that can help determine sustained opportunities for the stakeholders. Exclusive information provided in the flu vaccine market report addresses various important questions required to understand and gain comprehensive knowledge about the market. Some of these questions are:

  • How is regulatory framework in different nations affecting the growth of flu vaccine market?
  • How has the flu vaccine market performed so far and how will it perform in the next decade?
  • What are winning strategies of key players in the flu vaccine market?
  • What are the opportunities market stakeholders are eyeing to strengthen their position in the global market?
  • What are development risks and competitive threats faced by the flu vaccine market players across different regions?

Research Methodology:

The research methodology followed for obtaining complete information regarding the developments in flu vaccine market involves conducting an in-depth market research with the help of various primary and secondary resources. By analyzing the information gathered through and verified by these resources, analysts could offer exclusive insights on how the flu vaccine market will grow and expand during the predefined period.

Analysts have conducted interviews and discussion with healthcare consultants, CEOs, KOLs, regional officers, and sales managers of companies in the supply chain of flu vaccine drugs. The data obtained through these discussions have contributed to the development of the flu vaccine market report as a primary resource.

Secondary resources referred by the analysts for the compilation of flu vaccine market report include company annual and financial reports, white papers, industrial association publications, research publications, and leading industry magazines. Other secondary resources are Global Alliance of Vaccine and Immunization (Gavi), International Society of Vaccines, and IFPMA.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Recent Developments
  • 1.3. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market

4. Global Flu Vaccine Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

  • 4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
  • 4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Spending Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Vaccination Rate
    • 5.2.2. Awareness about Flu and Flu Vaccination
    • 5.2.3. Availability of Flu Vaccine
    • 5.2.4. Demand for Flu Vaccine in Different Countries
    • 5.2.5. Collaboration among manufacturers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029
    • 6.3.1. Trivalent Flu Vaccine
    • 6.3.2. Quadrivalent Flu Vaccine
  • 6.4. Market Attractiveness Analysis By Product Type

7. Global Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Dosage Form

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Dosage Form, 2014 - 2018
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage Form, 2019 - 2029
    • 7.3.1. Intramuscular Injection
    • 7.3.2. Nasal Spray
    • 7.3.3. Intradermal Shot
  • 7.4. Market Attractiveness Analysis By Dosage Form

8. Global Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2018
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
    • 8.3.1. Institutional Sales
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Community Clinics
      • 8.3.1.3. Public Health Agencies
      • 8.3.1.4. Workplace Purchasing
    • 8.3.2. Retail Sales
      • 8.3.2.1. Retail Pharmacy
      • 8.3.2.2. Mail Order Pharmacy
  • 8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029, by Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2014 - 2018
  • 9.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2019 - 2029
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. South Asia
    • 9.3.5. East Asia
    • 9.3.6. Oceania
    • 9.3.7. Middle East and Africa (MEA)
  • 9.4. Market Attractiveness Analysis By Region

10. North America Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Product Type
    • 10.3.3. By Dosage Form
    • 10.3.4. By Distribution Channel
  • 10.4. Market Attractiveness Analysis
  • 10.5. Drivers and Restraints - Impact Analysis

11. Latin America Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Rest of Latin America
    • 11.3.2. By Product Type
    • 11.3.3. By Dosage Form
    • 11.3.4. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
  • 11.5. Drivers and Restraints - Impact Analysis

12. Europe Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. BENELUX
      • 12.3.1.7. Russia
      • 12.3.1.8. Rest of Europe
    • 12.3.2. By Product Type
    • 12.3.3. By Dosage Form
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. South Asia Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 13.4.1. By Country
      • 13.4.1.1. India
      • 13.4.1.2. Thailand
      • 13.4.1.3. Indonesia
      • 13.4.1.4. Malaysia
      • 13.4.1.5. Rest of South Asia
    • 13.4.2. By Product Type
    • 13.4.3. By Dosage Form
    • 13.4.4. By Distribution Channel
  • 13.5. Market Attractiveness Analysis
  • 13.6. Drivers and Restraints - Impact Analysis

14. East Asia Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product Type
    • 14.3.3. By Dosage Form
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. Oceania Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 15.3.1. By Country
      • 15.3.1.1. Australia
      • 15.3.1.2. New Zealand
    • 15.3.2. By Product Type
    • 15.3.3. By Dosage Form
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Flu Vaccine Market Analysis 2014-2018 and Forecast 2019-2029

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2014 - 2018
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 - 2029
    • 16.3.1. By Country
      • 16.3.1.1. GCC Countries
      • 16.3.1.2. Turkey
      • 16.3.1.3. Northern Africa
      • 16.3.1.4. South Africa
      • 16.3.1.5. Rest of Middle East and Africa
    • 16.3.2. By Product Type
    • 16.3.3. By Dosage Form
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies (Flu Vaccine)
  • 17.2. Market Share Analysis of Top Players
  • 17.3. Market Presence Analysis
    • 17.3.1. By Regional footprint of Players
    • 17.3.2. Product foot print by Players
    • 17.3.3. Channel Foot Print by Players

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. Sanofi Pasteur Inc. (Sanofi S/A)
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio
      • 18.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.1.4. Sales Footprint
      • 18.3.1.5. Strategy Overview
        • 18.3.1.5.1. Marketing Strategy
        • 18.3.1.5.2. Product Strategy
        • 18.3.1.5.3. Channel Strategy
    • 18.3.2. AstraZeneca
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio
      • 18.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.2.4. Sales Footprint
      • 18.3.2.5. Strategy Overview
        • 18.3.2.5.1. Marketing Strategy
        • 18.3.2.5.2. Product Strategy
        • 18.3.2.5.3. Channel Strategy
    • 18.3.3. CSL Ltd. (Seqirus)
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio
      • 18.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.3.4. Sales Footprint
      • 18.3.3.5. Strategy Overview
        • 18.3.3.5.1. Marketing Strategy
        • 18.3.3.5.2. Product Strategy
        • 18.3.3.5.3. Channel Strategy
    • 18.3.4. Abbott
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.4.4. Sales Footprint
      • 18.3.4.5. Strategy Overview
        • 18.3.4.5.1. Marketing Strategy
        • 18.3.4.5.2. Product Strategy
        • 18.3.4.5.3. Channel Strategy
    • 18.3.5. GlaxoSmithKline Plc.
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.5.4. Sales Footprint
      • 18.3.5.5. Strategy Overview
        • 18.3.5.5.1. Marketing Strategy
        • 18.3.5.5.2. Product Strategy
        • 18.3.5.5.3. Channel Strategy
    • 18.3.6. Serum Institute of India Pvt. Ltd.
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio
      • 18.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.6.4. Sales Footprint
      • 18.3.6.5. Strategy Overview
        • 18.3.6.5.1. Marketing Strategy
        • 18.3.6.5.2. Product Strategy
        • 18.3.6.5.3. Channel Strategy

19. Research Methodology

List of Tables

  • Table 01: Global Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 02: Global Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 03: Global Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 04: Global Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
  • Table 05: North America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 06: North America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 07: North America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 08: North America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 09: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 10: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 11: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 12: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 13: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 14: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 15: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 16: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 17: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 18: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 19: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 20: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 21: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 22: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 23: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 24: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 25: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 26: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 27: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 28: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 29: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
  • Table 30: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 31: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 32: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 33: China Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 34: China Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 35: China Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 36: India Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 37: India Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 38: India Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
  • Table 39: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
  • Table 40: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Dosage Form
  • Table 41: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel

List of Figures

  • Figure 01: Flu Vaccine Market Value ($ Mn), By Country (2018)
  • Figure 02: Global Flu Vaccine Market Value Share by Product Type (2019E)
  • Figure 03: Global Flu Vaccine Market Value Share by Dosage Form (2019E)
  • Figure 04: Global Flu Vaccine Market Value Share by Distribution Channel (2019E)
  • Figure 05: Global Flu Vaccine Market Value Share by Region (2019E)
  • Figure 06: Global Flu Vaccine Market Value Analysis (US$ Mn), 2014-2018
  • Figure 07: Global Flu Vaccine Market Value Analysis (US$ Mn), 2019-2029
  • Figure 08: Global Flu Vaccine Market Absolute $ Opportunity, 2014-2018
  • Figure 09: Global Flu Vaccine Market Absolute $ Opportunity, 2019-2029
  • Figure 10: Global Flu Vaccine Market Share Analysis (%) By Product Type, 2019 & 2029
  • Figure 11: Global Flu Vaccine Market Y-o-Y Growth (%) By Product Type, 2019-2029
  • Figure 12: Global Flu Vaccine Market Attractiveness Analysis, By Product Type
  • Figure 13: Global Flu Vaccine Market Share Analysis (%) By Dosage Form, 2019 & 2029
  • Figure 14: Global Flu Vaccine Market Y-o-Y Growth (%) By Dosage Form, 2019-2029
  • Figure 15: Global Flu Vaccine Market Attractiveness Analysis, By Dosage Form
  • Figure 16: Global Flu Vaccine Market Share Analysis (%) By Distribution Channel, 2019 & 2029
  • Figure 17: Global Flu Vaccine Market Y-o-Y Growth (%) By Distribution Channel, 2019-2029
  • Figure 18: Global Flu Vaccine Market Attractiveness Analysis, By Distribution Channel
  • Figure 19: Global Flu Vaccine Market Share Analysis (%) By Region, 2019 & 2029
  • Figure 20: Global Flu Vaccine Market Y-o-Y Growth (%) By Region, 2019-2029
  • Figure 21: Global Flu Vaccine Market Attractiveness Analysis, By Region
  • Figure 22: North America Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 23: North America Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 24: North America Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 25: North America Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 26: North America Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 27: North America Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 28: North America Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 29: North America Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 30: North America Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 31: North America Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 32: North America Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 33: North America Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 34: North America Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 35: North America Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 36: Latin America Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 37: Latin America Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 38: Latin America Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 39: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 40: Latin America Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 41: Latin America Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 42: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 43: Latin America Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 44: Latin America Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 45: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 46: Latin America Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 47: Latin America Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 48: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 49: Latin America Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 50: Europe Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 51: Europe Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 52: Europe Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 53: Europe Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 54: Europe Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 55: Europe Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 56: Europe Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 57: Europe Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 58: Europe Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 59: Europe Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 60: Europe Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 61: Europe Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 62: Europe Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 63: Europe Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 64: South Asia Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 65: South Asia Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 66: South Asia Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 67: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 68: South Asia Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 69: South Asia Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 70: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 71: South Asia Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 72: South Asia Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 73: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 74: South Asia Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 75: South Asia Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 76: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 77: South Asia Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 78: East Asia Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 79: East Asia Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 80: East Asia Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 81: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 82: East Asia Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 83: East Asia Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 84: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 85: East Asia Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 86: East Asia Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 87: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 88: East Asia Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 89: East Asia Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 90: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 91: East Asia Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 92: Oceania Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 93: Oceania Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 94: Oceania Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 95: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 96: Oceania Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 97: Oceania Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 98: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 99: Oceania Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 100: Oceania Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 101: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 102: Oceania Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 103: Oceania Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 104: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 105: Oceania Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 106: MEA Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 107: MEA Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 108: MEA Flu Vaccine Market Analysis by Country - 2019 & 2029
  • Figure 109: MEA Flu Vaccine Market Y-o-Y Growth Projections by Country, 2019-2029
  • Figure 110: MEA Flu Vaccine Market Attractiveness Analysis by Country, 2019-2029
  • Figure 111: MEA Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 112: MEA Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 113: MEA Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 114: MEA Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 115: MEA Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 116: MEA Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 117: MEA Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 118: MEA Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 119: MEA Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 120: Emerging Countries Market Value Share (2019 E)
  • Figure 121: Emerging Countries Flu Vaccine Market Value (US$ Mn), By Key Countries, 2014-2029
  • Figure 122: China Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 123: China Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 124: China Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 125: China Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 126: China Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 127: China Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 128: China Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 129: China Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 130: China Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 131: China Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 132: China Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 133: India Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 134: India Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 135: India Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 136: India Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 137: India Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 138: India Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 139: India Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 140: India Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 141: India Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 142: India Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 143: India Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
  • Figure 144: Brazil Flu Vaccine Market Size (US$ Mn), 2014-2018
  • Figure 145: Brazil Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2019-2029
  • Figure 146: Brazil Flu Vaccine Market Analysis by Product Type - 2019 & 2029
  • Figure 147: Brazil Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2019-2029
  • Figure 148: Brazil Flu Vaccine Market Attractiveness Analysis by Product Type, 2019-2029
  • Figure 149: Brazil Flu Vaccine Market Analysis by Dosage Form -2019 & 2029
  • Figure 150: Brazil Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2019-2029
  • Figure 151: Brazil Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2019-2029
  • Figure 152: Brazil Flu Vaccine Market Analysis by Distribution Channel -2019 & 2029
  • Figure 153: Brazil Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2019-2029
  • Figure 154: Brazil Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2019-2029
Back to Top